Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emergency department considerations regarding erectile dysfunction.

Judd E Hollander1

  • 1Department of Emergency Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104-4283, USA.

The American Journal of Cardiology
|January 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is an ED discharge safe after a single cardiac troponin: Analysis of the FAST-TRAC study.

The American journal of emergency medicine·2026
Same author

Emergency Care Outside of the Four Walls of the Emergency Department.

JAMA network open·2026
Same author

Do Patient-Important Outcomes Differ by Care Setting? Findings from Semi-Structured Interviews with Individuals with Diabetes.

Healthcare (Basel, Switzerland)·2025
Same author

Is There an Urgent Need for Categorization?

Annals of emergency medicine·2025
Same author

Want to Grow? Just Say Yes…Mostly.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2025
Same author

Effect of host-protein test (TRAIL/IP-10/CRP) on antibiotic prescription and emergency department or urgent care center return visits: The JUNO pilot randomized controlled trial.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2025
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Emergency physicians need guidance on managing acute coronary syndromes (ACS) in patients using phosphodiesterase 5 (PDE5) inhibitors. This ensures safe and effective treatment by clarifying nitrate administration timing and necessary patient education.

Area of Science:

  • Emergency Medicine
  • Cardiology
  • Pharmacology

Background:

  • Emergency departments face unique challenges with incomplete patient information.
  • Outpatient erectile dysfunction (ED) treatments can affect emergency care for acute coronary syndromes (ACS).
  • Current evidence-based guidance for emergency physicians managing these interactions is limited.

Purpose of the Study:

  • To provide evidence-based guidance for emergency physicians treating patients with potential ACS who are also using phosphodiesterase 5 (PDE5) inhibitors.
  • To clarify the safe time interval between PDE5 inhibitor use and nitrate administration.
  • To outline modifications for ACS treatment in patients with recent PDE5 inhibitor use.

Main Methods:

  • Literature review and synthesis of current clinical guidelines.

Related Experiment Videos

  • Analysis of pharmacokinetic and pharmacodynamic interactions between PDE5 inhibitors and nitrates.
  • Development of recommendations for clinical practice in emergency settings.

    • Main Results:

    • Specific timeframes for nitrate administration post-PDE5 inhibitor use are crucial to avoid dangerous hypotension.
    • Management strategies for ACS must be adapted based on recent PDE5 inhibitor use.
    • Patient education regarding PDE5 inhibitors and nitrate use is essential for risk minimization.

    Conclusions:

    • Emergency physicians require clear protocols for managing ACS in patients using PDE5 inhibitors.
    • Adherence to recommended time intervals and modified treatment plans improves patient safety.
    • Enhanced patient communication about PDE5 inhibitor use is vital during all medical encounters.